APA

Podda A., Bona G., Canciani G., Pistilli A. M., Contu B., Furlan R., Meloni T., Stramare D., Titone L. & Rappuoli R. (19950911). Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. : The Journal of pediatrics.

Chicago

Podda A, Bona G, Canciani G, Pistilli A M, Contu B, Furlan R, Meloni T, Stramare D, Titone L and Rappuoli R. 19950911. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. : The Journal of pediatrics.

Harvard

Podda A., Bona G., Canciani G., Pistilli A. M., Contu B., Furlan R., Meloni T., Stramare D., Titone L. and Rappuoli R. (19950911). Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. : The Journal of pediatrics.

MLA

Podda A, Bona G, Canciani G, Pistilli A M, Contu B, Furlan R, Meloni T, Stramare D, Titone L and Rappuoli R. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. : The Journal of pediatrics. 19950911.